A Study to Evaluate the Clinical Pharmacology and Safety of C1-esterase Inhibitor Administered by the Subcutaneous Route

Clinical trial NCT01576523 · COMPLETED

Trial details

NCT number: NCT01576523
Sponsor: CSL Behring
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hereditary Angioedema Types I and II

Start date: 2012-04-01
Primary completion: 2012-12-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.